OTHER INFORMATION
−Removed: During the three months ended March 31, 2025, no director or officer of the Company adopted , terminated or modified a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K of the Exchange Act.
+Added: During the three months ended June 30, 2025, no director or officer of the Company adopted , terminated or modified a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K of the Exchange Act.
Number Description
25 unchanged sentences
4.18 Description of the Company’s Securities (incorporated by reference to Exhibit 4.5 to the Registrant's Annual Report on Form 10-K, filed with the SEC on March 5, 2024).
−Removed: Form of Securities Purchase Agreement, dated January 3, 2025, by and among the Company and the Purchasers named therein (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K, filed with the SEC on January 6, 2025).
−Removed: At the Market Offering Agreement, dated February 21, 2025, by and between the Company and H.C.
−Removed: Wainwright, LLC (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed with the SEC on February 21, 2025).
−Removed: Separation Agreement, effective as of February 20, 2025, by and between Gülsen Kama and the Company (incorporated by reference to Exhibit 10.19 to the Registrant's Annual Report on Form 10-K, filed with the SEC on March 31, 2025).
−Removed: Bionano Genomics, Inc.
−Removed: 2020 Inducement Plan, as amended (incorporated by reference to Ex hibit 99.3 of the Registrant’s Registration Statement on Form S-8 (File No.
−Removed: 333-286325 ), filed with the SEC on March 31, 2025).
+Added: 10.1 S ixth Amendment to the Lease by and between the Registrant and The Irvine Company, LLC, dated J une 27 , 202 5 .
31.1 Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
15 unchanged sentences
BIONANO GENOMICS, INC.
+Added: August 14, 2025
Erik Holmlin, Ph.D.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.